Kedudukan dalam Saham
#20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Perubahan (1 hari)
-1.15%
Perubahan (1 tahun)
21.17%
Perdagangan Sinew Pharma Inc. (6634)
Harga 6634 dengan permodalan pasaran b
Modal pasaran bagi Sinew Pharma Inc.(6634)
Modal Pasaran: $136.47M
Sehingga August 2026, Sinew Pharma Inc. mempunyai modal pasaran sebanyak $136.47M. Ini menjadikan Sinew Pharma Inc. syarikat ke-20222nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Sinew Pharma Inc. dari 2017 hingga 2026
6634 berbanding dengan 5 teratas yang paling popular stocks
| Harga 6634 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.092T
|
+3,731,327.31%
|
|
|
|
|
$4.581T
|
+3,356,803.19%
|
|
|
|
|
$4.188T
|
+3,069,080.83%
|
|
|
|
|
$3.594T
|
+2,633,824.83%
|
|
|
|
|
$2.811T
|
+2,059,918.65%
|
